Navigation Links
Getting close to nature is good for you

Connecting with nature can improve your health and wellbeing, say researchers in this week's BMJ. The theory is known as ecotherapy: restoring health through contact with nature.

Use of wildlife in some therapies is reported to improve quality of life, write the authors. Smaller animals (for example, squirrels, owls, and raccoons) have been used successfully in therapies for children with emotional and behavioural problems.

People who take part in conservation projects report subjective health benefits, ascribed to being outdoors and to feeling part of a greater system connecting beyond the individual. Such projects can help overcome social isolation, develop skills, and improve employment prospects, as well as provide the known benefits associated with exercise.

Although initial research has been promising, the UK needs robust health impact assessments of wildlife projects to determine their objective therapeutic value, say the authors.

English Nature has advocated a national strategy to encourage people to reconnect with nature and benefit from proximity to wildlife.

Partnerships between healthcare providers and nature organisations to share and exchange expertise could create new policies that recognise the interdependence between healthy people and healthy ecosystems, they conclude.


'"/>

Source:BMJ-British Medical Journal


Page: 1

Related biology news :

1. Getting an evolutionary handle on life after reproduction
2. Getting old? Slowing down? Blame inefficient mitochondria
3. Getting to the heart of the heart
4. Chemicals in tattoo inks need closer scrutiny
5. Doctors closer to using gene analysis to help trauma patients
6. Proteomics brings researchers closer to understanding microbes that produce acid mine drainage
7. Computers close in on protein structure prediction
8. New results validating Pall prion reduction filter disclosed at ISBT Congress
9. Scientists closer to new cancer detection method
10. Scientists observe how a close bond activates the immune system
11. Stroke treatment a step closer after trial
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... -- AIC announces that it has just released a new white paper authored by Zettar ... high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... Dec. 8, 2016 Savannah River Remediation ... and selected NewTechBio,s NT-MAX Lake & Pond ... beneficial bacteria, in conjunction with Hexa Armor/ Rhombo ... with National Pollutant Discharge Elimination System requirements. ... a steady history of elevated pH levels, above ...
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
Breaking Biology Technology: